Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland

Lung, Respiratory and Thoracic Cancer
Do you want to read an article? Please log in or register.